Drug Approval | January 19, 2024
Zydus and Synthon inks licensing and supply agreement for Palbociclib Tablets for US market
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
The product has been in-licensed from Strides and will be commercialized by Amneal
This approval showcases Teva’s proven strengths in complex generic formulations development and device engineering
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
Subscribe To Our Newsletter & Stay Updated
